Dr. Hagins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Wheeler St
Savannah, GA 31405Phone+1 912-356-2953Fax+1 912-356-2465
Education & Training
HCA Healthcare/Mercer University School of Medicine/Memorial Health University Medical CenterResidency, Family Medicine, 1989 - 1992
Morehouse School of MedicineClass of 1989
Certifications & Licensure
GA State Medical License 1992 - 2025
Publications & Presentations
PubMed
- 1 citationsHigh efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Black adults in the United States, including those with pre-existing HIV resistance and s...Kristen Andreatta, Michelle L D'Antoni, Silvia Chang, Aiyappa Parvangada, Ross Martin
Journal of Medical Virology. 2024-10-01 - 1 citationsDEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-based Regimen Switch Strategy to Manage Integrase Inhibitor-related Weight Gain.David Anderson, Moti Ramgopal, Debbie P Hagins, Johnnie Lee, Richard Bruce Simonson
Clinical Infectious Diseases. 2024-09-04 - 2 citationsSwitch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovi...Anthony M Mills, Giuliano Rizzardini, Moti N Ramgopal, Olayemi O Osiyemi, Johannes R Bogner
The Lancet. HIV. 2024-06-01
Press Mentions
Switching HIV Regimens Safe in African-AmericansMarch 10th, 2020
First Efficacy Trials on Switch to RPV/FTC/TAF for HIV Yield Positive ResultsSeptember 20th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
